[Modern therapeutic trends in the conservative treatment of ischemic disease of the lower extremities].
The author reviews contemporary knowledge of the pathogenesis of ischaemia of the lower extremities. As to therapeutic provision which influence in a favourable way pathological processes associated with the development of ischaemia an important place is held by pentoxiphylline (Trental) which reduces the pathologically raised adhesiveness and activity of leucocytes causing an excessive immune response; it reduces the viscosity of blood and procoagulation activity.